You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Drug Price Trends for LORATADINE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for LORATADINE

Average Pharmacy Cost for LORATADINE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
LORATADINE 10 MG TABLET 00904-6852-72 0.05176 EACH 2024-12-18
LORATADINE 10 MG TABLET 00904-6852-89 0.05176 EACH 2024-12-18
LORATADINE 10 MG ODT 00536-1367-07 0.65233 EACH 2024-12-18
LORATADINE 10 MG TABLET 00904-6852-61 0.05176 EACH 2024-12-18
LORATADINE-D 24HR TABLET 00904-5833-48 0.55364 EACH 2024-12-18
LORATADINE 10 MG ODT 72888-0029-09 0.65233 EACH 2024-12-18
LORATADINE 10 MG ODT 46122-0539-52 0.65233 EACH 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for LORATADINE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
LORATADINE 5MG/5ML SYRUP Golden State Medical Supply, Inc. 00121-0849-40 40X10ML 85.20 2023-06-15 - 2028-06-14 FSS
LORATADINE 5MG/5ML SYRUP Golden State Medical Supply, Inc. 51672-2073-08 120ML 2.49 0.02075 ML 2023-06-15 - 2028-06-14 FSS
ALLERGY RELIEF (LORATADINE) Geri-Care Pharmaceutical Corp 57896-0658-03 30 0.99 0.03300 EACH 2021-09-18 - 2026-06-14 FSS
ALLERGY RELIEF (LORATADINE) Geri-Care Pharmaceutical Corp 57896-0658-03 30 1.29 0.04300 EACH 2023-07-01 - 2026-06-14 FSS
ALLERGY RELIEF (LORATADINE) Geri-Care Pharmaceutical Corp 57896-0658-09 90 3.29 0.03656 EACH 2021-06-15 - 2026-06-14 FSS
ALLERGY RELIEF (LORATADINE) Geri-Care Pharmaceutical Corp 57896-0658-09 90 3.17 0.03522 EACH 2023-07-01 - 2026-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

LORATADINE Market Analysis and Financial Projection

Loratadine Market Analysis and Price Projections

Introduction to Loratadine

Loratadine is a widely used antihistamine medication, classified as a second-generation or non-sedating antihistamine. It is primarily used to treat allergy-related symptoms such as allergic rhinitis (hay fever) and chronic idiopathic urticaria. Loratadine works by inhibiting the activity of histamine, a substance produced by the body during allergic responses, thereby relieving symptoms like sneezing, itching, runny nose, and watery eyes[3].

Global Market Size and Growth

The global loratadine market is experiencing significant growth driven by several key factors.

  • Current Market Size: As of 2024, the global loratadine API market size is estimated to be USD 165.245 million[1].
  • Forecasted Growth: The market is projected to expand at a Compound Annual Growth Rate (CAGR) of 3.50% from 2024 to 2031, reaching USD 210.238 million by 2031[1].
  • Alternative Projections: Another report suggests that the global loratadine market will reach USD 219.4 million by 2032, with a CAGR of 3.7% during the forecast period (2024-2032)[3].

Regional Market Analysis

The loratadine market is distributed across various regions, each with its own growth dynamics.

North America

  • Market Share: North America is the most significant global loratadine market shareholder, driven by a high disease burden and the presence of numerous manufacturers[3].
  • CAGR: The region is expected to grow at a CAGR of 3.4% over the forecast period[3].
  • Country-wise Data: The United States holds a substantial share, with a market size of USD 52.151 million in 2024 and a CAGR of 1.5% from 2024 to 2031. Canada and Mexico also contribute significantly, with CAGRs of 2.5% and 2.2%, respectively[1].

Europe

  • Market Share: Europe holds a moderate share of the market, with countries like the UK experiencing increased demand due to an aging population and extended pollen seasons[3].
  • CAGR: The European market is expected to grow at a CAGR of 2% from 2024 to 2031[1].

Asia-Pacific

  • Market Share: The Asia-Pacific region is anticipated to exhibit a CAGR of 3.8% over the forecast period, driven by expanding awareness of allergic ailments, a growing senior population, and rising prevalence of lifestyle diseases[3].
  • Country-wise Data: India, with its vast population and increasing health awareness, is a key driver in this region[3].

Latin America and Middle East & Africa

  • Market Share: Latin America holds around 5% of the global revenue, with a market size of USD 8.262 million in 2024 and a CAGR of 2.9% from 2024 to 2031. The Middle East and Africa hold around 2% of the global revenue, with a CAGR of 3.2% during the same period[1].

Market Drivers

Several factors are driving the growth of the loratadine market:

  • Increasing Prevalence of Allergies: The rising prevalence of allergies globally is a significant driver, as it increases the demand for antihistamine medications like loratadine[3][4].
  • Lifestyle Changes: Changing lifestyles and the growing awareness of allergic ailments are also contributing to market growth[3].
  • Favorable Regulatory Landscape: Regulatory support and awareness campaigns, such as World Allergy Week, further boost the market[3].

Market Restraints

Despite the growth, there are some challenges facing the loratadine market:

  • Limited Treatment Options: The limited treatment options for certain allergies, such as food allergies, pose challenges to the market's growth[4].

Market Opportunities

The loratadine market also presents several opportunities:

  • Self-Medication Trend: The trend towards self-medication for common allergies has created a significant market for loratadine[4].
  • Online Pharmacy Segment: The increasing use of online platforms for purchasing medications is another opportunity, with the online pharmacy segment dominating the market[4].

Product Segments

The loratadine market is segmented into various product forms, each with its own market dynamics:

  • Tablets: The tablets segment dominates the market, with a substantial revenue driven by the presence of numerous industry competitors producing loratadine tablets in various strengths[4].
  • Syrup: The loratadine syrup market, though smaller, is expected to grow at a CAGR of 2% from 2022 to 2030, emphasizing the need for pediatric and adult formulations[5].

Distribution Channels

The distribution channels for loratadine also play a crucial role in its market growth:

  • Online Pharmacies: The online pharmacy segment has significant revenue, driven by the broad availability and accessibility of online platforms[4].

Key Takeaways

  • The global loratadine market is projected to grow significantly, driven by the increasing prevalence of allergies and favorable regulatory landscapes.
  • North America and the Asia-Pacific region are key markets, with North America dominating due to its high disease burden and the Asia-Pacific region growing rapidly due to increasing health awareness.
  • The market faces challenges such as limited treatment options for certain allergies but presents opportunities in self-medication trends and online pharmacy segments.

FAQs

Q: What is the current global market size of the loratadine API market? A: The global loratadine API market size is estimated to be USD 165.245 million in 2024[1].

Q: What is the projected CAGR for the global loratadine market from 2024 to 2031? A: The global loratadine market is projected to expand at a CAGR of 3.50% from 2024 to 2031[1].

Q: Which region is expected to dominate the loratadine market? A: North America is expected to dominate the loratadine market due to its high disease burden and the presence of numerous manufacturers[3].

Q: What are the main drivers of the loratadine market growth? A: The main drivers include the increasing prevalence of allergies, lifestyle changes, and a favorable regulatory landscape[3][4].

Q: What is the growth projection for the loratadine syrup market? A: The loratadine syrup market is expected to grow at a CAGR of 2% from 2022 to 2030[5].

Sources

  1. Cognitive Market Research: Loratadine API Market Report 2024 (Global Edition)[1].
  2. EIN Presswire: Loratadine Market 2023: Projected to reach USD Million by 2030[2].
  3. Straits Research: Loratadine Market to be Worth USD 219.4 million by 2032[3].
  4. GlobeNewswire: Loratadine Market to Garner $221.4 Billion, Globally, by 2033[4].
  5. UnivDatos: Loratadine Syrup Market Analysis, Trends and Forecast 2022-2030[5].

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.